PPARδ agonist is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-09-27. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
== SC == sc – (s) Sardinian language (ISO 639-1 code) Sc – (s) Scandium SC (s) Cruiser Submarine (US Navy hull classification) c Saint Kitts and Nevis (FIPS 10-4 country code; from Saint Christopher) Seychelles (ISO 3166 digram) South Carolina (postal symbol) SCA (i) Service Contract Act Sexual Compulsives Anonymous Society for Creative Anachronism SCAP – (a) Supreme Commander Allied Powers (Allied occupation of Japan) sccm – (s) Standard cubic centimetre per minute (unit of measurement of fluid flow) sccs – (s) Standard cubic centimetre per second (unit of measurement of fluid flow) scfh – (s) Standard cubic foot per hour (unit of measurement of fluid flow) scfm – (s) Standard cubic foot per minute (unit of measurement of fluid flow) scfs – (s) Standard cubic foot per second (unit of measurement of fluid flow) SCG – (s) Serbia and Montenegro (ISO 3166 trigram; defunct since 2006) SCHIMS – (i) Soldier Combat Helmet Identification Marking System SCHIP – (a) State Children's Health Insurance Program (U.S.; often pronounced "ess-chip") SciFi – Science Fiction sCJD – (i) Sporadic Creutzfeldt–Jakob disease SCM – (i) Surface Contamination Module SCMODS – (s) State, County, Municipal Offender Data System SCN – (p) Suprachiasmatic Nucleus SCNT – (i) Somatic Cell Nuclear Transfer SCO (i) Santa Cruz Operation (initials later used by SCO Group) (s) Scotland (FIFA trigram; not eligible for an ISO 3166 or IOC trigram) (a) Shanghai Cooperation Organisation SCOTUS – (a) Supreme Court of the United States SCR – (s) Seychelles rupee (ISO 4217 currency code) SCRAM – (a) Safety Control Rod Axe Man SCS (i) Scan Correlated Shift Soil Conservation Service SCSI (a) Small Computer System Interface ("scuzzy") (i) Strategic and Combat Studies Institute SCT – (s) Scattered Sky (METAR Code) SCTP – (i) Stream Control Transmission Protocol Scuba – (a) Self Contained Underwater Breathing Apparatus SCUF – Slow Continuous Ultrafiltration SCUFN – (i) Sub-Committee on Undersea Feature Names (of GEBCO)
=== Host specificity and community responses === Most EcM hosts show low levels of specificity, and can form symbioses with many distantly related fungi. This may have evolutionary benefits to the plant in two ways: 1) the plant's seedlings are more likely to be able to form mycorrhizas in a wide array of habitats; and 2) the plant can make use of different fungi that vary in their ability to access nutrients. EcM fungi exhibit various levels of specificity for their plant hosts, and the costs and benefits to their specialization are not well understood. For example, the suilloid group, a monophyletic assemblage containing the genera Suillus, Rhizopogon, Gomphidius and others, shows an extreme degree of specificity, with almost all of its members forming ectomycorrhizas with members of the Pinaceae. However, many other fungal groups exhibit a very broad host range. Host plants that are taxonomically related have more similar EcM fungal communities than do taxa that are more distantly related. Similarly, molecular phylogenetic studies have shown that fungi derived from a common ancestor are more likely to have hosts that are taxonomically related. The maturity of the host environment, or successional status, may also affect the variety of EcM fungal communities present. Other indirect factors can also play a role in the EcM fungal community, such as leaf fall and litter quality, which affect calcium levels and soil pH.
== Premise == Like previous Half-Life games, Half-Life 2: Episode Three was a first-person shooter (FPS). It was to be the last in a trilogy of episodic games that would continue the story of the 2004 game Half-Life 2. Episode One was released in 2006, followed by Episode Two in 2007. Valve's president, Gabe Newell, said he considered the trilogy the equivalent of Half-Life 3. Episode Three was set in the Arctic and focused on the missing Borealis ship mentioned in Episode Two and another Valve game, Portal 2. It featured a weapon that created barriers and ramps from ice, and a blob-like enemy that could divide itself, consume other enemies and pass through grates. A leak of Valve development files in 2026 included a model for the Weaponizer, a weapon used to turn objects into ammunition. In 2009, reports surfaced that Valve was working with sign language and on a deaf character. Newell said that Gordon's companion, Alyx Vance, had programmed her pet robot, Dog, to use sign language, inspired by a deaf person she had a crush on. In 2010, Newell spoke of "broadening the emotional palette" of the Half-Life series, and said the next game may return to "genuinely scaring the player". According to Newell, whereas the original Half-Life (1998) saw the mysterious G-Man transform the protagonist, Gordon Freeman, into his tool, and Half-Life 2 saw Freeman being used by G-Man, the episodes would see G-Man lose control.
Sources: en.wikipedia.org
They have two sets of teeth, including one set of larger sharp, teeth coming out of the mandibular and premaxillary bones to grasp and control the prey. The other set of teeth, located posteriorly and connected to the hyomandibular bone, is made up of pharyngeal tooth patches, which are used for sorting out nutrients and grinding down larger pieces of food. Another three bones make up the lower jaw: the dentary, the angular, and the surangular. The cranial surface of the skull is made up of the nasals, the antorbital, the lacrimal, the parietal, the intertemporal, the post parietal, the supratemporal, the extra scapular, the post temporal, and the opercular. The entirety of the skull is attached to the girdle through another set of bones.
== Clinical implications == Immunisation of mothers against male-specific minor histocompatibility (H-Y) antigens has a pathogenic role in many cases of secondary recurrent miscarriage, that is, recurrent miscarriage in pregnancies succeeding a previous live birth. An example of this effect is that the male:female ratio of children born prior and subsequent to secondary recurrent miscarriage is 1.49 and 0.76 respectively.
G-actin: despite its conserved nature, it has a varying number of paralogs (at least six in mammals). Creatine kinase, the presence of which in the blood can be used as an aid in the diagnosis of myocardial infarction, exists in 3 paralogs. Hyaluronan synthase, the enzyme responsible for the production of hyaluronan, has three isoforms in mammalian cells. UDP-glucuronosyltransferase, an enzyme superfamily responsible for the detoxification pathway of many drugs, environmental pollutants, and toxic endogenous compounds has 16 known isoforms encoded in the human genome. G6PDA: normal ratio of active "isoforms" in cells of any tissue is 1:1 shared with G6PDG. This is precisely the normal "isoform" ratio in hyperplasia. Only one of these "isoforms" is found during neoplasia.
=== Other honours === Crick was elected a Fellow of the Royal Society (FRS) in 1959, a Fellow of the International Academy of Humanism, and a Fellow of CSICOP. In 1987, Crick received the Golden Plate Award of the US Academy of Achievement. The inscription on the helices of a DNA sculpture (which was donated by James Watson) outside Thirkill Court, Clare College, Cambridge, reads: "The structure of DNA was discovered in 1953 by Francis Crick and James Watson while Watson lived here at Clare." and on the base: "The double helix model was supported by the work of Rosalind Franklin and Maurice Wilkins." Another sculpture entitled Discovery, by artist Lucy Glendinning, was installed on 13 December 2005 in Abington Street, Northampton. According to the late Lynn Wilson, chairman of the Wilson Foundation, "The sculpture celebrates the life of a world class scientist who must surely be considered the greatest Northamptonian of all time — by discovering DNA he unlocked the whole future of genetics and the alphabet of life." Westminster City Council unveiled a green plaque to Francis Crick on the front façade of 56 St George's Square, Pimlico, London SW1 on 20 June 2007; Crick lived in the first floor flat, together with Robert Dougall of BBC radio and later TV fame, a former Royal Navy associate. At a meeting of the executive council of the Committee for Skeptical Inquiry (CSI) (formerly CSICOP) in Denver, Colorado in April 2011, Crick was selected for inclusion in CSI's Pantheon of Skeptics.
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.